Modulation of bone morphogenic protein signaling in T-cells for cancer immunotherapy

Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment

(2012) Douglas Hanahan et al.   CANCER CELL

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

(2012) Suzanne L Topalian et al.   CURRENT OPINION IN IMMUNOLOGY

Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily

(2012) Andrew P. Hinck   FEBS LETTERS

Immunology beats cancer: a blueprint for successful translation

(2012) Drew M Pardoll   NATURE IMMUNOLOGY

Tumor associated regulatory dendritic cells

(2012) Yang Ma et al.   SEMINARS IN CANCER BIOLOGY

Natural Innate and Adaptive Immunity to Cancer

(2011) Matthew D. Vesely et al.   Annual Review of Immunology

Comprehensive analysis of TGF-β and BMP receptor interactomes

(2011) Mohammad Poorgholi Belverdi et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

Differential effects of inhibition of bone morphogenic protein (BMP) signalling on T-cell activation and differentiation

(2011) Yumiko Yoshioka et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8

(2011) D T N Shola et al.   ONCOGENE

Tumor-reactive CD4+T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

(2010) Sergio A. Quezada et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate

(2010) Ye Zheng et al.   NATURE

Adoptive immunotherapy of cancer using CD4+ T cells

(2009) Pawel Muranski et al.   CURRENT OPINION IN IMMUNOLOGY

Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations

(2009) H. Senta et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Synergistic effect of TGF-β superfamily members on the induction of Foxp3+ Treg

(2009) Ling Lu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Promising novel immunotherapies and combinations for prostate cancer

(2009) Philip M Arlen et al.   Future Oncology

TCR Repertoire and Foxp3 Expression Define Functionally Distinct Subsets of CD4+ Regulatory T Cells

(2009) M. Kuczma et al.   JOURNAL OF IMMUNOLOGY

Activin A Promotes the TGF- -Induced Conversion of CD4+CD25- T Cells into Foxp3+ Induced Regulatory T Cells

(2009) S. Huber et al.   JOURNAL OF IMMUNOLOGY

Foxp3-Deficient Regulatory T Cells Do Not Revert into Conventional Effector CD4+ T Cells but Constitute a Unique Cell Subset

(2009) M. Kuczma et al.   JOURNAL OF IMMUNOLOGY

Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor

(2009) Yann M Kerdiles et al.   NATURE IMMUNOLOGY

Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages

(2009) Andrew Gray et al.   VACCINE

Signaling cross-talk between TGF-β/BMP and other pathways

(2008) Xing Guo et al.   CELL RESEARCH

Regulatory T Cells: Mechanisms of Differentiation and Function

(2007) Steven Z. Josefowicz et al.   Annual Review of Immunology